EXHIBIT 23.1

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

      We consent to the incorporation by reference in the Registration Statement
(Form S-3) and the related prospectus of Titan Pharmaceuticals, Inc. for the
registration of 7,031,986 shares of the common stock of our report dated
February 12, 1999, with respect to the consolidated financial statements of
Titan Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the
year ended December 31, 1998, filed with the Securities and Exchange Commission.

/s/ Ernst & Young LLP

Palo Alto, California
September 13, 1999


                                      II-5